Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Internal Medicine, 2015
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Yarchoan M, Agarwal P, Villanueva A, Rao S, Dawson LA, Karasic TB, Llovet JM, Finn RS, Groopman JD, El-Serag HB, Monga SP, Wang XW, Karin M, Schwartz RE, Tanabe KK, Roberts LR, Gunaratne PH, Tsung A, Brown KA, Lawrence TS, Salem R, Singal AG, Kim AK, Rabiee A, Resar L, Meyer J, Hoshida Y, He AR, Ghoshal K, Ryan PB, Jaffee EM, Guha C, Mishra L, Coleman CN, Ahmed MM.: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma Cancer Research 79 (17): 4326-4330,2019.
Karasic TB, Chiorean EG, Sebti SM, O'Dwyer PJ: A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors Targeted Oncology : 2019.
Kim Anna Reiss, Rosemarie Mick, Mark H. O'Hara, Ursina R. Teitelbaum, Thomas Benjamin Karasic, Charles John Schneider, Peter J. O'Dwyer, Danielle Karlson, Stacy Cowden, Mary Jane Fuhrer, Erica L. Carpenter, Austin A Pantel, Mehran Makvandi, David A. Mankoff, Katharine Nathanson, Kara Noelle Maxwell, Gregory Lawrence Beatty, Susan M. Domchek: A randomized phase II trial of niraparib plus either nivolumab or ipilimumab in patients with advanced pancreatic cancer whose cancer has not progressed on platinum-based therapy 2019 ASCO Annual Meeting TPS4161 : 2019.
Teresa Macarulla Mercade, Victor Moreno, Binu John, John Charles Morris, Michael B. Sawyer, Wei Peng Yong, Martin Gutierrez, Thomas Benjamin Karasic, Bruno Sangro, Yang Sheng-Shun, Carleen Gentry, Amy Kim, Pavan Kumar, Crystal MacKenzie, Nathalie Rioux, Joanne Schindler, Anand Selvaraj, Richard S. Finn: A phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC) patients (pts) 2019 ASCO Annual Meeting Abstract #4095 : 2019.
Saima Rathore, Mark H. O'Hara, Thomas Benjamin Karasic, Maryann Redlinger, Mark Alan Rosen, Christos Davatzikos, Peter O'Dwyer: Radiomic profiles via machine learning to predict response, overall survival, and KRAS status in metastatic colorectal tumors treated with FOLFOX/bevacizumab/hydroxychloroquine 2019 ASCO Annual Meeting Abstract #e15125 : 2019.
Karasic TB, O'Hara MH, Loaiza-Bonilla A, Reiss KA, Teitelbaum UR, Borazanci E, De Jesus-Acosta A, Redlinger C, Burrell JA, Laheru DA, Von Hoff DD, Amaravadi RK, Drebin JA, O'Dwyer PJ: Effect of Gemcitabine and nab-Paclitaxel With or Without
Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2
Randomized Clinical Trial JAMA Oncology : 2019.
Kim A. Reiss Binder, Rosemarie Mick, Mark O'Hara, Ursina Teitelbaum, Thomas Karasic, Charles Schneider, Peter J. O'Dwyer, Erica Carpenter, Austin Pantel, Mehran Makvandi, David Mankoff, Katherine Nathanson, Kara Maxwell, Stacy Cowden, Mary Jane Fuhrer, Janae Romeo, Gregory L. Beatty, Susan Domchek: A Phase II, single arm study of maintenance rucaparib in patients with platinum-sensitive advanced pancreatic cancer and a pathogenic germline or somatic mutation in BRCA1, BRCA2 or PALB2 2019 AACR Annual Meeting Abstract #CT234 : 2019.
Nikhil Grandhi, Jahan Mohiuddin, John Plastaras, James M. Metz, John Lukens, Thomas Karasic, Kim Reiss-Binder, Edgar Ben-Josef, Andrzej Wojcieszynski: Outcomes of Pencil Beam Scanning Proton Therapy for Anal Cancer: A Single Institution Study American Radium Society 2019 Abstract #20 : 2019.
Kim Anna Reiss, Edgar Ben-Josef, Nevena Damjanov, Maarouf Hoteit, Thomas Benjamin Karasic, Erica Carpenter, Lisa DiCicco, Luis Anna Garcia-Marcano, Rosemarie Mick, Robert H Vonderheide: A pilot study of galunisertib (LY2157299 monohydrate) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC) 2019 GI ASCO Abstract #270 : 2019.
Saima Rathore 1, 2, , Muhammad Aksam Iftikhar 3, Ahmad Chaddad 4, Tamim Niazi 4, Thomas Karasic 5 and Michel Bilello 1, 2: Segmentation and Grade Prediction of Colon Cancer Digital Pathology Images Across Multiple Institutions https://doi.org/10.3390/cancers11111700 : 2019.
3400 Civic Center BlvdPCAM South Tower 10-102
Phone: (215) 614-1858
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.